WuXi PharmaTech Starts Moving Scientists to New Facility

WuXi PharmaTech Starts Moving Scientists to New Facility

January 16, 2007

 
    SHANGHAI, China, Jan. 16 /Xinhua-PRNewswire/ -- WuXi
PharmaTech, China's leading provider of pharmaceutical
R&D outsourcing services announced today that it has
begun moving the first group of scientists to its
state-of-the-art Tianjin research facility, which first
became operational in December, 2006. Located in the
Tianjin Economic and Technical Development Zone (TEDA)
(also known as Tai Da), Tianjin PharmaTech is a wholly
owned subsidiary of WuXi PharmaTech Co., Ltd. 
    (Logo: http://www.xprn.com.cn/xprn/sa/200611271812.jpg
)

    The new facility aptly compliments the Shanghai
research campus with 130,000 sq. ft. of new laboratory
space.  Tianjin PharmaTech boasts an even higher advanced
equipment ratio than WuXi PharmaTech's other already very
well equipped facilities. 

    The TEDA Development Zone was one of China's first
state-level development areas and now encompasses an area
of over 27 sq. km.  With special support for high-tech
companies, TEDA and Tianjin are an ideal location for WuXi
PharmaTech to plant its seed of future growth.

    Often referred to as the "Gate of Beijing",
Tianjin is China's third largest city and offers numerous
high quality universities.  Drawing from these universities
and those of nearby Beijing, Tianjin PharmaTech will benefit
from a deep talent pool of qualified researchers. 

    "The commencement of Tianjin PharmaTech represents
new expansion, new government support, a broad talent pool
of qualified graduates, and a new state-of-the-art facility
that will grow with the needs of our collaborative
partners", commented Dr. Ge Li, Chairman and CEO of
WuXi PharmaTech.  "I am excited for the unique
opportunities and growth prospects our Tianjin facility
will offer to our existing and future partners,"
continued Dr. Li.
 
    About WuXi PharmaTech 

    Founded in 2001, Shanghai-based WuXi PharmaTech is
China's leading drug R&D service company.  As a
research-driven and customer-focused company, WuXi
PharmaTech offers global pharmaceutical and
biopharmaceutical companies a diverse, value-added, and
fully integrated portfolio of outsourcing services ranging
from discovery chemistry, and process chemistry to service
biology, bioanalytical chemistry, and large scale GMP
manufacturing.  WuXi PharmaTech assists its global partners
in shorting the cycle and lowering the cost of drug
discovery and development by providing cost-effective and
efficient outsourcing solutions that save our clients both
time and money.  Currently, our client list consists of 19
of the top 20 pharmaceutical, and 8 of the top 10
biopharmaceutical companies.  For more information, please
visit: http://www.pharmatechs.com .
  
    About Tianjin Economic and Technical Development Zone
(TEDA)

    The establishment of Tianjin Economic and Technological
Development Area¡¡ (TEDA) was given government approval on
December 6, 1984.  One of the country's first state-class
development areas, TEDA has developed into one of the
country's most influential hotbeds for high-tech and new
industries. But TEDA has a more ambitious goal for the new
century: to build "Asia's biggest and China's best
modern industrial area in the 21st century".  To make
that dream come true, TEDA has embarked upon another
arduous pioneering journey and jump-started diverse
projects zeroing in on better investment environment,
cityscape and habitability of this young urban area.  For
more information, please visit:
http://www.teda.gov.cn/englishnew/index.jsp .




    For more information, please contact:

     Sherry Shao 
     Tel:   [phone]
     Email: [e-mail]




SOURCE  WuXi PharmaTech Co., Ltd.